HALO today
$100.64-$0.03 (-0.03%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourLeaning Bullish
15 minLeaning Bullish
5 minLeaning Bearish
Daily trend turns down below $106.65
Key levels
Resistance$114.00
Resistance$107.41
Support$98.13
Support$82.26
Latest news & SEC filings
AnalystMorgan Stanley cuts Halozyme Therapeutics to Equal-Weight, lifts target to $109
AnalystHalozyme Therapeutics cut to Equalweight by Morgan Stanley
NewsHalo Minerals PLC unit receives provisional easement tied to Playa Verde
All HALO news →About Halozyme Therapeutics
Halozyme Therapeutics is a biopharmaceutical company that develops drug delivery technologies. Its main platform, ENHANZE, uses the enzyme rHuPH20 to allow injected drugs and fluids to be given subcutaneously instead of intravenously. The company licenses this technology to pharmaceutical partners such as Roche, Takeda, Pfizer, Janssen, AbbVie, Lilly, and Bristol-Myers Squibb, and earns royalties on approved partner products. It also sells its own products, including Hylenex and XYOSTED, and develops auto-injector devices. Halozyme is based in San Diego, California.
Based on the company's 10-K filed Feb 17, 2026.
Nasdaq · Healthcare
HALOZYME THERAPEUTICS, INC. (HALO)
What Is the Price Target for HALO?
SEPT Low Target
$79.00
SEPT Mid Target
$117.00
SEPT High Target
$149.00
Analyst Consensus
$117.00
Is HALO a Buy or Sell Right Now?
Thesis
- •Revenue growing 37.5% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HALO.
Start Free Trial →Is HALO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$124.78
35
Moat Score
NONE
5/9
Piotroski Score
4.6
Altman Z-Score
What Is Smart Money Doing with HALO?
Insider Signal
SELLING
0 buys / 15 sells (90d)
Congress Signal
BUYING
1 buys / 2 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Torley Helen | director officer | Buy | 20,000 | $368K | Oct 8, 2026 |
| Torley Helen | director officer | Sale | 4,810 | $520K | Oct 8, 2026 |
| Torley Helen | director officer | Sale | 3,090 | $337K | Oct 8, 2026 |
| Torley Helen | director officer | Sale | 11,900 | $1.3M | Oct 8, 2026 |
| Torley Helen | director officer | Sale | 200 | $22K | Oct 8, 2026 |
| Torley Helen | director officer | Buy | 20,000 | $368K | Oct 7, 2026 |
| Torley Helen | director officer | Sale | 8,600 | $955K | Oct 7, 2026 |
| Torley Helen | director officer | Sale | 10,300 | $1.2M | Oct 7, 2026 |
| Torley Helen | director officer | Sale | 900 | $102K | Oct 7, 2026 |
| Torley Helen | director officer | Sale | 200 | $23K | Oct 7, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HALO Growth Story
Revenue YoY
37.5%
3yr Revenue CAGR
28.4%
EPS Growth YoY
-25.36%
FCF Growth YoY
37.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for HALO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HALO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:40:52 | $100.05 | 49,500 | $$5.0M | SELL |
| 16:38:19 | $100.53 | 1,300 | $$131K | BUY |
| 16:38:19 | $100.53 | 8,293 | $$834K | MIDPOINT |
| 16:38:16 | $100.63 | 6,076 | $$611K | BUY |
| 16:36:29 | $100.66 | 1,500 | $$151K | BUY |
5 dark pool trades shown · $$6.7M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for HALO
PREVIEWSEPT Investing provides real-time options flow tracking for HALO, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $105 | Dec 17 | 399 | $$9240 | 6 | SWEEP |
| CALL | $105 | Dec 17 | 399 | $$6360 | 4 | SWEEP |
| PUT | $115 | Dec 18 | 35 | $$38.7K | 26 | SWEEP |
| PUT | $115 | Dec 18 | 35 | $$4467 | 3 | SWEEP |
| PUT | $115 | Nov 20 | 7 | $$37.7K | 26 | SWEEP |
5 options trades shown · 40% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for HALOZYME THERAPEUTICS, INC. (HALO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HALO — frequently asked questions
What is HALO stock price today?
HALOZYME THERAPEUTICS, INC. (HALO) is at $100.64, down 0.03% (-$0.03) at the Nov 13, 2026 close.
Why is HALO stock moving today?
Latest HALO news — Nov 11, 2026: Morgan Stanley cuts Halozyme Therapeutics to Equal-Weight, lifts target to $109 · Nov 11, 2026: Halozyme Therapeutics cut to Equalweight by Morgan Stanley
What is the HALO price target?
The average analyst price target for HALO is $117.00, ranging from $79 to $149, based on 9 analysts. Latest: Morgan Stanley downgrade on Nov 11, 2026.
What do analysts rate HALO?
Analyst ratings for HALO: 1 Buy, 16 Hold, 1 Sell — consensus Hold.
Did HALO beat earnings?
HALO last reported on Nov 5, 2026: EPS $8.75 vs $2.30 expected — a beat of 280.4%.
What is HALO's P/E ratio?
HALO trades at a P/E of 25.7 vs a Healthcare average of 17.2.
Does HALO pay a dividend?
HALO does not currently pay a dividend.
What are HALO support and resistance levels?
Support: $98.13, $82.26, $76.96. Resistance: $107.41, $114.00, $134.00.
What are insiders doing with HALO?
Insider activity: SELLING, 0 buys and 15 sells in the last 90 days.
What is the latest news on HALO?
Nov 11, 2026: Morgan Stanley cuts Halozyme Therapeutics to Equal-Weight, lifts target to $109 · Nov 11, 2026: Halozyme Therapeutics cut to Equalweight by Morgan Stanley · Nov 9, 2026: Halo Minerals PLC unit receives provisional easement tied to Playa Verde